Beranda › Kanker Paru › California › Oakland
Uji klinis Kanker Paru di Oakland, CA
6 studi untuk Kanker Paru mencari peserta di lokasi sekitar Oakland (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Kaiser Permanente-Oakland, Oakland
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Menerima pesertaFase 3
- Kaiser Permanente-Oakland, Oakland
Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
- Kaiser Permanente-Oakland, Oakland
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Kaiser Permanente-Oakland, Oakland
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Kaiser Permanente-Oakland, Oakland
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Kaiser Permanente-Oakland, Oakland
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Arlington, VA41 studi
- Washington, DC41 studi
- Chicago, IL41 studi
- Baltimore, MD40 studi
- Nashville, TN40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Oakland
- Kanker Payudara7 studi
- Leukemia Mieloid Akut7 studi
- Penyakit Sel Sabit7 studi
- Limfoma Burkitt6 studi
- Kanker Paru Non-Sel Kecil6 studi
- Kanker Prostat6 studi
- Neuroblastoma5 studi
- Kanker (semua jenis)5 studi
- Osteosarkoma4 studi
- Penyakit Alzheimer4 studi
- Adenokarsinoma Esofagus4 studi
- Melanoma4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.